2023年2月28日

2023年2月28日,項目利用聲樂生物標誌物的認知評估患者年齡在55歲以上的家庭環境探頭衛生、健康科技公司致力於將訪問健康監測,結合馬薩諸塞州總醫院(MGH)額顳葉障礙(FTD)單位,已經選擇的馬薩諸塞州人工智能和技術聯係保健中心的老化和阿茲海默氏症(MassAITC)領導一個試點研究著重於利用聲樂生物標誌物用於遠程檢測和監測的輕度認知障礙的家庭環境。由MassAITC和國家老齡問題研究所(NIA)的一個部門,美國國立衛生研究院(NIH)項目是一個170萬美元的贈款的一部分探索人工智能和其他先進技術的使用家庭護理。具體地說,它將評估的可行性獲得語音錄音的老年人的家庭環境,可用於縱向監測演講和記憶功能。“近90%的老年人希望盡可能長時間地呆在家園。數字技術,尤其是數字生物標誌物,有很大的潛力來支持這一轉變,”首席執行官大衛·劉說探頭的健康。“通過監控認知健康從遠處通過聲樂生物標誌物,探頭的技術可以幫助促進這種欲望的時代,這些患者提供的能力仍然在熟悉的環境中在不犧牲質量的護理。“項目將從FTD單位招收50名成年人。參與者將年齡在55歲以上,代表著一係列認知功能正常認知通過主觀認知能力下降,輕度認知障礙(MCI)和輕度癡呆。縱向研究將檢查潛在的探空儀的聲音生物標誌物平台監控和檢測認知功能的改變為個人在家裏。參與者將記錄10 - 15和響應不同的語音樣本的認知評估實驗室和從他們的個人智能手機在家裏。聲音錄音將聲學特性的分析與精神狀態,預計將提供深入了解的生物標記物可以作為有效的工具來跟蹤認知健康。 The pilot is part of MassAITC’s larger mission to realize the goal of aging at home through interdisciplinary research. It will serve as an important reference data set to further test and validate vocal biomarkers relevant to the detection or monitoring of cognitive impairment. This study builds on several current Sonde projects focused on testing cognitive biomarkers, including a multi-year strategic partnership with GN Group to research and develop commercial vocal biomarkers for MCI. “As the population of older adults continues to grow, there is a critical need for remote monitoring technologies that can detect cognitive impairment early and accurately,” said Deepak Ganesan, Director of the MassAITC. “By supporting a study that combines Sonde Health’s vocal biomarker technology and Massachusetts General Hospital’s expertise in clinical dementia research, we believe we’re one step closer to developing the tools and resources needed to elevate aging-in-place care models.” “With this pilot study, we are excited to partner with Sonde Health to contribute new insights into how voice-based remote monitoring of cognitive function for older adults will potentially augment specialized clinical evaluations,” said Brad Dickerson, MD, Director of the MGH Frontotemporal Disorders Unit and Professor of Neurology at Harvard Medical School. Research reported in this press release was supported by the NIA of the NIH under award number P30AG073107. previous post